Categories for Client News

The death rate from cancer in the U.S. dropped 2.4% from 2017 to 2018, the biggest single-year decline on record and a sign of the impact of new treatments on lung cancer especially, the American Cancer Society said.

Congress passed a federal funding bill that included $80 million specially set aside for childhood cancer research programs.

The Lupus Research Alliance has announced the 2020 Lupus Innovation Award recipients. These seven recipients are tackling projects that represent a wide breadth of scientific exploration of the disease.

To intelligently scale its grant-making efforts, The ALS Association selected Altum’s ProposalCentral for its ease-of-use and comprehensive capabilities. 

On November 6, the Food and Drug Administration is convening a meeting of outside experts to review the data from two Phase 3 clinical trials of a new drug developed for treating cognitive and functional decline in early Alzheimer’s disease

The Lupus Research Alliance, a Proposal Central customer, recently published findings that support further development by several companies of potential new lupus treatments.

An exciting and promising breakthrough for the treatment of ALS is now in clinical trials. The ALS Foundation and I AM ALS have petitioned the FDA to make the treatment available as soon as possible.

This is it! For months, you’ve contributed your time and energy, donated, raised money and maybe even shaved your head. And today that all culminates in the largest set of grants St. Baldrick’s makes all year.